Zobrazeno 1 - 10
of 274
pro vyhledávání: '"Massimo, Iavarone"'
Autor:
Margherita Rimini, Margarida Montes, Elisabeth Amadeo, Francesco Vitiello, Masatoshi Kudo, Toshifumi Tada, Goki Suda, Shigeo Shimose, Sara Lonardi, Fabian Finkelmeier, Francesca Salani, Lorenzo Antonuzzo, Fabio Marra, Massimo Iavarone, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Rodolfo Sacco, Ilario Giovanni Rapposelli, Mario Scartozzi, Pella Nicoletta, Luca Aldrighetti, Mara Persano, Silvia Camera, Federico Rossari, Silvia Foti, Takashi Kumada, Atsushi Hiraoka, Hideki Iwamoto, Mario Domenico Rizzato, Vera Himmelsbach, Gianluca Masi, Mattia Corradi, Ciro Celsa, Conti Fabio, Giovanni Luca Frassineti, Stefano Cascinu, Andrea Casadei-Gardini, Jose Presa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Recently, in Hepatocellular carcinoma (HCC) setting, the use of metformin has been associated to a trend toward worse response rate, overall survival and progression free survival in patients who received immunotherapy. The study population
Externí odkaz:
https://doaj.org/article/41799d524b5a43689733a5a5474189a2
Autor:
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Emilie Crouchet, Fabio Del Zompo, Yuji Teraoka, Alexandre Haller, Philippe Baltzinger, Soumith Paritala, Fahmida Rasha, Naoto Fujiwara, Cloé Gadenne, Nevena Slovic, Marine A. Oudot, Sarah C. Durand, Clara Ponsolles, Catherine Schuster, Xiaodong Zhuang, Jacinta Holmes, Ming-Lun Yeh, Hiromi Abe-Chayama, Mathias Heikenwälder, Angelo Sangiovanni, Massimo Iavarone, Massimo Colombo, Steven K. H. Foung, Jane A. McKeating, Irwin Davidson, Ming-Lung Yu, Raymond T. Chung, Yujin Hoshida, Kazuaki Chayama, Joachim Lupberger, Thomas F. Baumert
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically exp
Externí odkaz:
https://doaj.org/article/faee0116ddb14568af297762b93cc7d2
Autor:
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Foti, Silvia Camera, Bernardo Stefanini, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini, Margherita Rimini
Publikováno v:
Liver Cancer (2024)
Introduction The impact of etiology on response to immunotherapy in advanced hepatocellular carcinoma (HCC) is being debated, with contrasting findings between early and recent post-hoc analyses of IMbrave-150 and metanalyses of clinical trials of PD
Externí odkaz:
https://doaj.org/article/3da67a4e9b81471598019e46c12fc527
Autor:
Kyunghye Bang, Andrea Casadei‐Gardini, Changhoon Yoo, Massimo Iavarone, Min‐Hee Ryu, Sook Ryun Park, Hyung‐Don Kim, Young‐In Yoon, Dong‐Hwan Jung, Gil‐Chun Park, Chul‐Soo Ahn, Deok‐Bog Moon, Shin Hwang, Ki‐Hun Kim, Gi‐Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L. Chan, Massimo De Giorgio, Baek‐Yeol Ryoo, Sung‐Gyu Lee
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2572-2579 (2023)
Abstract Introduction Lenvatinib is approved for the treatment of patients with metastatic or recurrent hepatocellular carcinoma (HCC); however, clinical outcomes of lenvatinib therapy in patients with post‐liver transplantation (LT) HCC recurrence
Externí odkaz:
https://doaj.org/article/3a4d488f1ccf435b83b8ccfb949c2e89
Autor:
Maurizio Biselli, Nicola Reggidori, Massimo Iavarone, Matteo Renzulli, Lorenzo Lani, Alessandro Granito, Fabio Piscaglia, Stefania Lorenzini, Eleonora Alimenti, Giulio Vara, Paolo Caraceni, Angelo Sangiovanni, Massimo Marignani, Elia Gigante, Nicolò Brandi, Annagiulia Gramenzi, Franco Trevisani
Publikováno v:
Cancers, Vol 16, Iss 6, p 1080 (2024)
Background and aims: Sarcopenia has been associated with poor outcomes in patients with cirrhosis and hepatocellular carcinoma. We investigated the impact of sarcopenia on survival in patients with advanced hepatocellular carcinoma treated with Soraf
Externí odkaz:
https://doaj.org/article/10d9dbc1f0ca49d19749814eb7da3ee2
Autor:
Eloisa Franchi, Daniele Eliseo Dondossola, Giulia Maria Francesca Marini, Massimo Iavarone, Luca Del Prete, Clara Di Benedetto, Maria Francesca Donato, Barbara Antonelli, Pietro Lampertico, Lucio Caccamo
Publikováno v:
Cancers, Vol 16, Iss 5, p 1043 (2024)
The outcome of liver transplantation (LT) for hepatocarcinoma (HCC) is strongly influenced by HCC staging, which is based on radiological examinations in a pre-LT setting; concordance between pre-LT radiological and definitive pathological staging re
Externí odkaz:
https://doaj.org/article/be5112334c994dbdbbbf261aaf5d2b56
Autor:
Antonio Arrichiello MD, Anna Maria Ierardi MD, Alessandro Caruso MD, Pasquale Grillo MD, Letizia Di Meglio MD, Pierpaolo Biondetti MD, Massimo Iavarone MD, Angelo Sangiovanni MD, Salvatore Alessio Angileri MD, Chiara Floridi MD, Bradford Wood MD, Gianpaolo Carrafiello MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Tumor ablation is included in several major cancer therapy guidelines. One technical challenge of percutaneous ablation is targeting and verification of complete treatment, which is prone to operator variabilities and human imperfections and are dire
Externí odkaz:
https://doaj.org/article/a9fe5f434279407b8038bf1df1dcda54
Autor:
Pierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, Alessandro Caruso, Pasquale Grillo, Serena Carriero, Carolina Lanza, Salvatore Alessio Angileri, Angelo Sangiovanni, Massimo Iavarone, Giuseppe Guzzardi, Gianpaolo Carrafiello
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 24, p 7598 (2023)
Purpose: to evaluate the clinical impact of a protocol for the image-guided percutaneous microwave ablation (MWA) of hepatocellular carcinoma (HCC) that includes cone-beam computed tomography (CBCT), fusion imaging and ablation volume prediction in p
Externí odkaz:
https://doaj.org/article/3bbf2487283344088311911f223d6bf5
Autor:
Massimo Iavarone, Eleonora Alimenti, Toshifumi Tada, Shigeo Shimose, Goki Suda, Changhoon Yoo, Caterina Soldà, Fabio Piscaglia, Giulia Tosetti, Fabio Marra, Caterina Vivaldi, Fabio Conti, Marta Schirripa, Hideki Iwamoto, Takuya Sho, So Heun Lee, Mario Domenico Rizzato, Matteo Tonnini, Margherita Rimini, Claudia Campani, Gianluca Masi, Francesco Foschi, Mariangela Bruccoleri, Takumi Kawaguchi, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Shinya Fukunishi, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Atsushi Naganuma, Andrea Casadei-Gardini, Pietro Lampertico
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Introduction: Lenvatinib is indicated for the forefront treatment of advanced hepatocellular carcinoma (aHCC), but its use maybe limited by the risk of esophagogastric varices (EGV) bleeding. This study assessed the prevalence, predictors, and compli
Externí odkaz:
https://doaj.org/article/93da06996cb6459c9ed74984e1ecb6e5
Autor:
Emanuele Palomba, Marco Maggioni, Giulia Viero, Davide Mangioni, Rosa Lombardi, Barbara Antonelli, Daniele Dondossola, Massimo Iavarone, Anna Ludovica Fracanzani, Alessandra Bandera, Andrea Gori, Andrea Lombardi
Publikováno v:
Livers, Vol 1, Iss 3, Pp 132-137 (2021)
Rare liver diseases caused by ductal plate malformation, such as congenital hepatic fibrosis (CHF), Caroli syndrome, and polycystic liver disease, can have clinical manifestations such as recurrent cholangitis—frequently involving multidrug-resista
Externí odkaz:
https://doaj.org/article/58694906b1024402a4272c92fd0b7d5f